Sensorin Adds Senior Engineering and Operations Executives to Team

BURLINGAME, Calif.--(Business Wire)--
Sensorin, a privately held company focused on the development and
commercialization of a proprietary, novel self-calibrating pH measurement
platform for bioprocess and other industrial applications, today announced four
key additions to the company`s leadership. Dr. James A. Wilkins has been named
Chief Technology Officer and joins Sensorin from Genentech; Dean A. Mansour,
P.E., has been named Vice President of Engineering and joins the company from
Carl Zeiss Meditec; and Robert W. Carroll has been named Vice President of
Operations and Manufacturing and formally joins the company, after serving as a
high level advisor. In addition, Robert Sebes, a successful analytical tools
serial entrepreneur and investor joins the company`s Board of Directors.

"We are very pleased to welcome four seasoned professionals to the Sensorin
team," said Carolyn R. Kahn, Ph.D., Sensorin Founder, President and Chief
Executive Officer. "Jim joins the company with over 25 years of executive
experience in biopharmaceutical manufacturing and chemical engineering. Dean has
over 20 years of experience in the development and manufacture of leading-edge
analytical products, at both large companies and small firms. Bob Carroll has
been a senior operations executive at analytical tools corporations that are
well established, at companies entering the commercial phase and start-ups for
over 25 years. Bob Sebes has been in the industry over 35 years. Their wealth of
experience and leadership will be invaluable as we prepare to launch our first
product for the biopharmaceutical market in 2010 and begin to address additional
market opportunities for our unique sensing technology."

Jim Wilkins was most recently Director, Technology Assessment and Transfer at
Genentech and earlier served as an executive in process development and
manufacturing at Alexion Pharmaceutics. He has held biophysics and chemical
engineering research faculty positions at Yale University and Johns Hopkins
Universities, Jim earned his B.A. from the University of Texas at Austin, holds
a Ph.D. in Biochemistry from the University of Tennessee.

Dean Mansour most recently led a team of engineers making sophisticated optical
analytic tools for Carl Zeiss Meditec. He directed programs at Laserscope for
the GreenLight medical laser and its disposable fiber. At Applied Materials Dean
worked on electron-beam technology mask pattern generation systems. He led a
team at Imatron in a joint development program with Siemens for medical imaging.
Dean began his career at the Stanford Linear Accelerator, after earning his BSME
at the University of California at Berkeley.

Bob Carroll has consulted to over 20 emerging technology companies over the past
eight years. Previously, Bob served as the VP Materials and Manufacturing
Operations at Affymetrix, Inc. He joined Affymetrix in its early commercial
stage and served through six years of rapid growth and expansion. Prior to that,
Bob served at Applied Biosystems as VP Site Operations and grew with it through
its acquisition by Perkin Elmer, serving as Director of Worldwide Distribution
and Division Vice President. Bob earned his B.S. Electrical Engineering at Case
Institute of Technology and a Manufacturing Management program with the General
Electric Corporation.

Robert Sebes is a private investor with 30 years experience in forming,
operating and transitioning rapid growth analytical instrument businesses. Bob
is a partner and serves on the board of a number of small analytical instrument
companies. As CEO of SensIR Technologies he led the successful commercialization
of the first FT-IR based products for out of lab use. As COO of Spectra-Tech and
VP of ASI Applied Systems Bob was instrumental in building the infrastructure to
support the rapid growth of both companies. Spectra Tech was sold to Nicolet
(now Thermo Fischer Scientific) and ASI was sold to Mettler.

About Sensorin

Sensorin is developing and commercializing a novel, proprietary and versatile
sensing technology platform. The company is initially focusing on pH measurement
in high-value manufacturing, where an internally referenced, self-calibrating
system without drift is advantageous. The Sensorin system is solid state,
reliable, accurate and robust for deployment in process applications. The
company plans to launch its first commercial pH sensing system for biologics
manufacturing in 2010. For more information on Sensorin and its technology,
please visit http://www.sensorin.com.

Sensorin
Carolyn R. Kahn, 650-522-9324
info@sensorin.com
or
Kureczka/Martin Associates
Joan E. Kureczka, 415-821-2413
jkureczka@comcast.net

Copyright Business Wire 2009